A detailed history of Adar1 Capital Management, LLC transactions in Natera, Inc. stock. As of the latest transaction made, Adar1 Capital Management, LLC holds 2,500 shares of NTRA stock, worth $418,375. This represents 0.06% of its overall portfolio holdings.

Number of Shares
2,500
Previous 4,250 41.18%
Holding current value
$418,375
Previous $601 Million 29.72%
% of portfolio
0.06%
Previous 0.11%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 14, 2025

SELL
$132.23 - $171.87 $231,402 - $300,772
-1,750 Reduced 41.18%
2,500 $422 Million
Q1 2025

May 15, 2025

BUY
$132.63 - $177.0 $563,677 - $752,250
4,250 New
4,250 $601 Million

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $16.2B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Adar1 Capital Management, LLC Portfolio

Follow Adar1 Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Adar1 Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Adar1 Capital Management, LLC with notifications on news.